Literature DB >> 25670928

Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.

Alex B Ryder1, James C Zimring2, Jeanne E Hendrickson1.   

Abstract

Red blood cell (RBC) alloimmunization may occur following transfusion or pregnancy/delivery. Although observational human studies have described the immunogenicity of RBC antigens and the clinical significance of RBC alloantibodies, studies of factors influencing RBC alloimmunization in humans are inherently limited by the large number of independent variables involved. This manuscript reviews data generated in murine models that utilize transgenic donor mice, which express RBC-specific model or authentic human blood group antigens. Transfusion of RBCs from such donors into nontransgenic but otherwise genetically identical recipient mice allows for the investigation of individual donor or recipient-specific variables that may impact RBC alloimmunization. Potential donor-related variables include methods of blood product collection, processing and storage, donor-specific characteristics, RBC antigen-specific factors, and others. Potential recipient-related variables include genetic factors (MHC/HLA type and polymorphisms of immunoregulatory genes), immune activation status, phenotype of regulatory immune cell subsets, immune cell functional characteristics, prior antigen exposures, and others. Although murine models are not perfect surrogates for human biology, these models generate phenomenological and mechanistic hypotheses of RBC alloimmunization and lay the groundwork for follow-up human studies. Long-term goals include improving transfusion safety and minimizing the morbidity/mortality associated with RBC alloimmunization.

Entities:  

Keywords:  Alloimmunization; Murine models; RBC; Transfusion

Year:  2014        PMID: 25670928      PMCID: PMC4280453          DOI: 10.1159/000368995

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  109 in total

1.  Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients.

Authors:  H K Ho; S Y Ha; C K Lam; G C Chan; T L Lee; A K Chiang; Y L Lau
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

2.  Receipt of older RBCs does not predispose D-negative recipients to anti-D alloimmunization.

Authors:  Mark H Yazer; Darrell J Triulzi
Journal:  Am J Clin Pathol       Date:  2010-09       Impact factor: 2.493

3.  The use of the mechanical fragility test in evaluating sublethal RBC injury during storage.

Authors:  J S Raval; J H Waters; A Seltsam; E A Scharberg; E Richter; A R Daly; M V Kameneva; M H Yazer
Journal:  Vox Sang       Date:  2010-11       Impact factor: 2.144

4.  Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin.

Authors:  Sangeeta Pahuja; Mukta Pujani; Santosh Kumar Gupta; Jagdish Chandra; Manjula Jain
Journal:  Hematology       Date:  2010-06       Impact factor: 2.269

5.  Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).

Authors:  Elliott Vichinsky; Lynne Neumayr; Sean Trimble; Patricia J Giardina; Alan R Cohen; Thomas Coates; Jeanne Boudreaux; Ellis J Neufeld; Kristy Kenney; Althea Grant; Alexis A Thompson
Journal:  Transfusion       Date:  2013-07-25       Impact factor: 3.157

Review 6.  Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review.

Authors:  D Bratosin; J Mazurier; J P Tissier; J Estaquier; J J Huart; J C Ameisen; D Aminoff; J Montreuil
Journal:  Biochimie       Date:  1998-02       Impact factor: 4.079

7.  Recombinant blood group proteins facilitate the detection of alloantibodies to high-prevalence antigens and reveal underlying antibodies: results of an international study.

Authors:  Axel Seltsam; Franz Wagner; Mark Lambert; Tom Bullock; Nicole Thornton; Erwin A Scharberg; Daniela Grueger; Clemens Schneeweiss; Rainer Blasczyk
Journal:  Transfusion       Date:  2014-03-18       Impact factor: 3.157

8.  Comparing alloimmunization in preterm infants after transfusion of fresh unmodified versus stored leukocyte-reduced red blood cells.

Authors:  R G Strauss; D G Cordle; J Quijana; N E Goeken
Journal:  J Pediatr Hematol Oncol       Date:  1999 May-Jun       Impact factor: 1.289

9.  Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion.

Authors:  Justine S Liepkalns; Chantel M Cadwell; Sean R Stowell; Eldad A Hod; Steven L Spitalnik; James C Zimring
Journal:  Transfusion       Date:  2012-10-03       Impact factor: 3.157

Review 10.  Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety.

Authors:  Paula H B Bolton-Maggs; Hannah Cohen
Journal:  Br J Haematol       Date:  2013-09-14       Impact factor: 6.998

View more
  30 in total

1.  Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.

Authors:  David R Gibb; Jingchun Liu; Prabitha Natarajan; Manjula Santhanakrishnan; David J Madrid; Stephanie C Eisenbarth; James C Zimring; Akiko Iwasaki; Jeanne E Hendrickson
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

Review 2.  Transfusion-related red blood cell alloantibodies: induction and consequences.

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

3.  Responder individuality in red blood cell alloimmunization.

Authors:  Christoph Gassner
Journal:  Transfus Med Hemother       Date:  2014-11-14       Impact factor: 3.747

4.  The impact of vaccination on RBC alloimmunization in a murine model.

Authors:  P Natarajan; M Santhanakrishnan; C A Tormey; J E Hendrickson
Journal:  Vox Sang       Date:  2017-06-08       Impact factor: 2.144

Review 5.  Cellular immune responses in red blood cell alloimmunization.

Authors:  James C Zimring; Krystalyn E Hudson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 6.  Red blood cell storage lesion: causes and potential clinical consequences.

Authors:  Tatsuro Yoshida; Michel Prudent; Angelo D'alessandro
Journal:  Blood Transfus       Date:  2019-01       Impact factor: 3.443

Review 7.  Drug delivery by erythrocytes: "Primum non nocere".

Authors:  Carlos H Villa; Jerard Seghatchian; Vladimir Muzykantov
Journal:  Transfus Apher Sci       Date:  2016-10-31       Impact factor: 1.764

8.  Reduced MHC alloimmunization and partial tolerance protection with pathogen reduction of whole blood.

Authors:  Rachael P Jackman; Marcus O Muench; Heather Inglis; John W Heitman; Susanne Marschner; Raymond P Goodrich; Philip J Norris
Journal:  Transfusion       Date:  2016-11-18       Impact factor: 3.157

9.  B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice.

Authors:  David R Gibb; Jingchun Liu; Manjula Santhanakrishnan; Prabitha Natarajan; David J Madrid; Seema Patel; Stephanie C Eisenbarth; Christopher A Tormey; Sean R Stowell; Akiko Iwasaki; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2017-08-23       Impact factor: 3.157

Review 10.  Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.

Authors:  Carlos H Villa; Douglas B Cines; Don L Siegel; Vladimir Muzykantov
Journal:  Transfus Med Rev       Date:  2016-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.